Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Colorcon
Medtronic
Boehringer Ingelheim
McKesson
McKinsey

Last Updated: January 23, 2020

DrugPatentWatch Database Preview

Enalapril maleate; hydrochlorothiazide - Generic Drug Details

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

What are the generic sources for enalapril maleate; hydrochlorothiazide and what is the scope of patent protection?

Enalapril maleate; hydrochlorothiazide is the generic ingredient in two branded drugs marketed by Acp Nimble, Dr Reddys Labs Ltd, Ivax Sub Teva Pharms, Mylan, Nostrum Labs Inc, Taro Pharm Inds, Upsher Smith Labs, and Bausch, and is included in eight NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for enalapril maleate; hydrochlorothiazide. Six suppliers are listed for this compound.

Recent Litigation for enalapril maleate; hydrochlorothiazide

Identify potential future generic entrants

District Court Litigation
Case NameDate
Apotex, Inc. v. Mylan Pharmaceuticals, Inc.2012-04-20
Apotex, Inc. v. UCB, Inc.2012-04-20

See all enalapril maleate; hydrochlorothiazide litigation

Pharmacology for enalapril maleate; hydrochlorothiazide
Synonyms for enalapril maleate; hydrochlorothiazide
151035-56-2
C20H28N2O5.C7H8ClN3O4S2.C4H4O4
Co-Renitec
Enalapril maleate / hydrochlorothiazide
Enalapril maleate mixture with hydrochlorothiazide
Hydrochlorothiazide / enalapril maleate
LS-178460
SCHEMBL2525336

US Patents and Regulatory Information for enalapril maleate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075909-002 Oct 15, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Acp Nimble ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075727-002 Sep 18, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Ivax Sub Teva Pharms ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075736-002 Mar 25, 2003 DISCN No No   Start Trial   Start Trial   Start Trial
Mylan ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 075624-001 Sep 18, 2001 AB RX No No   Start Trial   Start Trial   Start Trial
Upsher Smith Labs ENALAPRIL MALEATE AND HYDROCHLOROTHIAZIDE enalapril maleate; hydrochlorothiazide TABLET;ORAL 076116-002 Sep 19, 2001 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for enalapril maleate; hydrochlorothiazide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995   Start Trial   Start Trial
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-003 Jul 12, 1995   Start Trial   Start Trial
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986   Start Trial   Start Trial
Bausch VASERETIC enalapril maleate; hydrochlorothiazide TABLET;ORAL 019221-001 Oct 31, 1986   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Express Scripts
Harvard Business School
McKinsey
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.